The new Metabolomics system from ESA promises to speed up biomarker
discovery and reduce the overwhelming amounts of data often
associated with these studies.
Biotech contract manufacturer Diosynth and PDL Biopharma have
extended their agreement for the commercial supply of PDL's heart
attack treatment Retavase (reteplase), a move that signals the end
of manufacturing issues PDL experienced...
The International Society for Pharmaceutical Engineering (ISPE) has
released its latest industry guide, covering the commissioning and
qualification of pharmaceutical water and steam systems.
Albany Molecular Research (AMRI) has slipped again in the fourth
quarter of 2006 recording an operating loss of $2.5m (€1.9m) - six
per cent worse than the same quarter the previous year - despite
encouraging revenue growth in its...
A new international agreement will eliminate customs duties on
pharmaceuticals and chemical intermediates traded between the major
nations dealing in the industry. The move is set to save EU
pharmaceutical companies around €230m in...
A new partnership between India's Reliance Life Sciences (RLS) and
Ireland's GeneMedix will provide new contract opportunities for
European contract bio-manufacturers.
Italian contract manufacturer Procos has just opened a US office -
a move that will allow the company to offer custom synthesis
services directly to its US customers.
The US Food and Drug Administration (FDA) have issued
Kentucky-based Omnicare with a blunt warning letter outlining the
firm's quality and safety lapses at its repackaging facility in
Toledo.
French firm Valois Pharma will be providing Generex with a novel
valve for its pressurised metered dose inhaler (pMDI), used for its
innovative method of buccal delivery of insulin.
Therapeutic drugs can now be smoked like cigarettes thanks to a
novel drug delivery device developed by new player Alexza
Pharmaceuticals. The inhaled drugs hit the bloodstream much quicker
than with other drug delivery techniques,...
A combination therapy to help smokers kick the habit has begun
evaluation in Phase I pilot studies in the US. A sustained-release
formulation of Cary Pharmaceutical's QuitPak has been developed
with IntelGenx Technologies as...
The massive R&D reshuffle Roche announced last week in its
pharmaceutical business will have no impact on any of the company's
outsourcing activities, a company spokesperson said.
A new start up company in the UK has been formed with ambitions to
shape itself into a global early-phase drug development services
group through an acquisition-based strategy.
European scientists have introduced a dental prosthesis capable of
dosing drugs, which they suggest could be a more convenient option
than swallowing pills.
Scientists have mapped the most important genes associated with the
risk of developing Type II diabetes, bringing a genetic test to
identify those most at risk a step closer.
US firm SCOLR Pharma has dropped development plans for a controlled
release phenylephrine (PE) formulation, in light of slow progress
in the over-the-counter (OTC) PE market.
Heavyweight Pfizer is the latest pharmaceutical to cut
manufacturing capacity and shut down plants as it announces the
closure and sale of active pharmaceutical ingredient (API)
facilities in Ireland.
Scientists have discovered a new method of enhancing the activity
of a protein that can dramatically extend lifespan, opening up the
possibility of a new 'anti-aging' drug.
Applied Biosystems are soon to launch their next generation genetic
analysis platform into a market that should allow a whole new wave
of biological understanding.
A naturally occurring molecule helps protect the immune system from
being destroyed by HIV and could open up a new way of fighting the
effects of the virus, according to new research.
Pharmaceutical companies manufacturing vaccines to protect against
avian flu outbreaks will be protected from product liability claims
according to new regulations announced by the US Department of
Health and Human Services (HHS).
US-based sterile experts Mediatech has entered into a business
agreement with US-based packaging and filling supplier Rapak to
market and sell aseptic filling equipment to satisfy a gap in the
market.
This week Lonza took over the reigns of two new US business units
from Cambrex after completing the largest acquisition in its
company history and also announced a capability expansion at its
Czech Republic site.
A multinational team of researchers based in the UK has found a way
to make carbon nanotubes easily cross biological barriers, opening
up the potential for a new form of drug delivery.
PerkinElmer will now offer a new lab equipment relocation service
to support customers who need to move and require special care for
their testing and manufacturing equipment.
Indian generics company Ranbaxy Laboratories has signed a
development and marketing agreement with generic injectables
company Zenotech Laboratories to produce its first biosimilar, a
granulocyte-colony stimulating factor (G-CSF;...
AstraZeneca has continued to rapidly refocus and bolster its
biologics pipeline through collaboration deals, this time with a
deal for antibody producing technology.
In this week's review of activity within the preclinical research
services arena, new deals have emerged involving Immunicon,
Novartis, Southern Research Institute and Absorption Systems.
Cardinal Health has reached an agreement with the US Food and Drug
Administration (FDA) on plans to resume manufacture and sale of its
Alaris (SE) line of infusion pumps. Units were seized and
production halted following grave safety...
Contract manufacturer Lonza has completed its acquisition of two
Cambrex subsidiaries, research bioproducts and microbial
biopharmaceutical, in a move that is fuelled by its strategic move
into biopharmaceuticals.
Swedish packaging manufacturer Cerbo has developed a novel closure
for tablet bottles as a user-friendly alternative for those who
have limited dexterity in their hands and fingers.
Roche is the latest large pharma company to restructure its
research and development into smaller disease-specific divisions to
help get drugs on the market faster.
Wyeth Pharmaceuticals is expanding its research into small
molecules schizophrenia drugs and biopharmaceuticals to treat
haemophilia, having announced three deals in a day earlier this
week.
US-based drug delivery firm, BioDelivery Sciences International
(BDSI), has asked for approval to start clinical trials of a soya
bean-based delivery technology that would lead to the first oral
version of amphotericin B, a widely-used...
UK-based firm BioProgress has developed novel tablet cores that
mean pills which were previously very difficult to coat can be
reformulated and easily coated using the company's innovative
TabWrap technology.
